NEUPATH HEALTH TO PRESENT AT THE 2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

Key Takeaways

• CEO Stephen Lemieux to present at Bloom Burton conference April 22, 2026.
• 30‑minute virtual session includes Q&A; webcast replay available 180 days.
• NeuPath runs one of Canada’s largest community‑based chronic‑pain networks.
• Conference links U.S., Canadian, international investors to Canadian healthcare firms.

Pulse Analysis

NeuPath Health has built a sizable footprint across Canada by locating multidisciplinary clinics in community settings, allowing patients to receive insured chronic‑pain and sports‑medicine care outside traditional hospitals. This model aligns with the publicly funded system’s push for cost‑effective, outpatient solutions, and it positions the company to capture rising demand as an aging population and heightened awareness of musculoskeletal disorders drive utilization. By integrating both insured and select non‑insured services, NeuPath creates diversified revenue streams while maintaining a patient‑centered approach.

The upcoming Bloom Burton & Co. Healthcare Investor Conference serves as a strategic showcase for NeuPath. The event draws a blend of U.S., Canadian and global investors seeking exposure to high‑growth Canadian health‑care assets. A live virtual presentation, followed by one‑on‑one meetings, offers the company an opportunity to articulate its expansion roadmap, discuss capital‑raising plans, and field investor questions on market dynamics and regulatory outlook. Visibility at such a forum can accelerate funding cycles, enhance share liquidity, and potentially attract strategic alliances that accelerate clinic roll‑outs.

Industry‑wide, the shift toward community‑based pain management reflects broader trends in health‑care delivery: decentralization, value‑based care, and the integration of multidisciplinary teams. As insurers and governments prioritize outpatient services to curb hospital costs, providers like NeuPath stand to benefit from policy support and increased referral volumes. However, the sector remains sensitive to regulatory changes and competition from emerging tele‑health platforms. NeuPath’s participation in the conference signals confidence in its growth trajectory and its intent to leverage investor capital to expand its network and innovate service offerings.